Similar to insulin, certain GLP-1 agonists are used to treat diabetes
Semaglutide GLP-1 enhances insulin release, particularly when blood sugar levels are elevated, thereby aiding in better glucose control
(accessed June 2022) 7Bydureon 2 mg prolonged release suspension for injection in pre-filled pen (BCise)
The study, presented at the European Congress of Obesity (ECO) and led by researchers at University College London, also found that semaglutide brought about cardiovascular benefits for its participants, regardless of their starting weight or the amount of weight that they had lost
These differences matter clinically: larger average weight loss translates into bigger improvements in blood pressure, glycemic measures, sleep apnea metrics, mobility, and quality of life for many patients